Health Consequences of Unplanned Pregnancies Versus Contraception

  • R. W. Rochat


Virtually everyone considers at least once in his or her life the health consequences of childbearing or family planning. Many still view the addition of each child as an inevitable gift of God or an act of fate. Others have learned that they may plan both the number and the timing of the births of their children. To the extent that conception and childbearing are viewed as controllable events, it is useful to examine the consequences of different strategies of control.


Family Planning Oral Contraceptive Infant Death Maternal Mortality Ectopic Pregnancy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.



  1. 1.
    Hatcher RA, Stewart GK, Stewart F et al (1981): Contraceptive Technology 1980–1981, Irvington Pub., New York.Google Scholar
  2. 2.
    Kaminetzky HA, Ingelman-Sundbert A (eds.) (1979): Proceeding of an international symposium: A reappraisal of fertility control risks and benefits. Int J Gynaecol Obstet, 16: 447–578.Google Scholar
  3. 3.
    Moghissi KS (1979): Controversies in Contraception. Williams and Wilkins, Baltimore.Google Scholar
  4. 4.
    Rochat RW, Ory HW, Schulz KF (1978): Methods for measuring safety and health hazards of presently available fertility regulating agents in the developing world. Singapore J Obstet Gynec, 9: 1–15.Google Scholar
  5. 5.
    Sciarra JJ, Zatuchni Gl, Speidel JJ (eds) (1978): Risks, benefits and controversies in fertility control. Harper and Row, Hagerstown, Md.Google Scholar
  6. 6.
    Suchindran CM Rochat RW, Krasowski RS, Leeds (1980): FERTMORT, a computer model to study mortality risks of different birth control strategies. In: Modeling and Simulation, Vol. II, Part 4, Social Economics, Proceeding of the Eleventh Annual Pittsburgh Conference on Modeling and Simulation, 1421–1428, University of Pittsburg, Pittsburg.Google Scholar

Pregnancy-Related Mortality

  1. 7.
    David HP, Matejcek (1981): Children born to women denied abortion. An update. Fam Plann Perspect, 13: 32–39.PubMedCrossRefGoogle Scholar
  2. 8.
    Liskin LS (1980): Complications of abortion in developing countries. Population Reports Series F, No. 7, Pregnancy Termination, Johns Hopkins University.Google Scholar
  3. 9.
    Rochat RW (1981): Maternal mortality in the United States of America. World Health Statistics, 34: 2–13.Google Scholar
  4. 10.
    Rochat RW, Jabeen S, Rosenberg MJ, Measham AR, Khan AR, Obaidullah M, Gould P (1981): Maternal and abortion related deaths in Bangladesh, 1978–1979. Int J Gynaecol Obstet, 19: 155–164.PubMedCrossRefGoogle Scholar
  5. 11.
    Rochat RW, Rubin GL, Selik R et al (1981): Changing the definition of maternal mortality. A new look at the postpartum interval. Lancet 1: 831.PubMedCrossRefGoogle Scholar
  6. 12.
    Westoff CF (1980): Abortions averted by sterilization in Korea, 1977–1978. Farn Plann Perspect, 6: 60–64.CrossRefGoogle Scholar


  1. 13.
    Auber JM, Lubell I, Schima M (1980): Mortality risk associated with female sterilization. Int J Gynaecol Obstet, 18: 406–410.Google Scholar
  2. 14.
    Chaturachinda K (1980): The use of the laparoscope in rural Thailand. Int J Gynaecol Obstet, 18: 414–419.PubMedGoogle Scholar
  3. 15.
    Grimes DA, Peterson HB, Rosenberg MJ (1981): Sterilization-attributable deaths in Bangladesh. Int J Gynaecol Obstet (in press).Google Scholar
  4. 16.
    Rosenberg MJ, Rochat RW, Akbar J (1981): Sterilization in Bangladesh. Mortality, morbidity and risk factors. Presented at American Public Health Association, October 1981, Los Angeles.Google Scholar

Oral Contraception

  1. 17.
    Ory HW (1981): Maximizing the non-contraceptive benefits of oral contraceptive use. Presented at Leuven, Belgium, September 25, 1981.Google Scholar
  2. 18.
    Ory HW, Rosenfield A, Landman L (1981): The pill at 20. An Assessment. Fam Plann Perspect, 12: 278–283.CrossRefGoogle Scholar
  3. 19.
    Petitti DB, Wingerd J, Pellegrin F, Ramcharan S (1979): Risk of vascular disease in women: Smoking, oral contraceptives, non-contraceptive estrogens, and other factors. JAMA, 243: 1150–1154.CrossRefGoogle Scholar


  1. 20.
    Burkman RT and The Women’s Health Study (1976): Association between intrauterine device and pelvic inflammatory disease. Obstet Gynecol, 57: 269–275.Google Scholar
  2. 21.
    Cates W, Ory HW, Rochat RW, Tyler CW (1976): The intrauterine device and deaths from spontaneous abortion. N Engl J Med, 295: 1155–1159.PubMedCrossRefGoogle Scholar


  1. 22.
    Greenspan AR, Hatcher RA, Moore M, Rosenberg MJ, Ory, HW (1980): The association of depo-medroxy-progesterone acetate and breast cancer. Contraception, 21: 563–570.PubMedCrossRefGoogle Scholar
  2. 23.
    Gold RB, Willson PD (1981): Depo-provera: new developments in a decade-old controversy. Fam Plann Perspect, 13: 35–39.PubMedCrossRefGoogle Scholar

Natural Family Planning

  1. 24.
    Wade ME, McCarthy P, Braunstein GD et al (1981): A randomized prospective study of the use- effectiveness of natural family planning. Am J Obstet Gynec, 141: 368–376.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • R. W. Rochat
    • 1
  1. 1.Department of Health and Human ServicesUnited States Public Health Service Centers for Disease ControlAtlantaUSA

Personalised recommendations